Susanne Kintscher

Ph.D., MS&T Lead Lentiviral Vector Manufacturing • Miltenyi Bioindustry

Susanne Kintscher conducted her PhD at the German Cancer Research Center in Heidelberg, Germany in the research area of therapeutic targeting of Human Papillomaviruses. She joined Miltenyi in 2011 and currently, as a lead for the MS&T team for lentiviral vector manufacturing for ex-vivo gene therapies, she is working with her colleagues to drive process validation strategies toward marketing authorization approval. Her focus is on translating process knowledge into GMP manufacturing in the challenging field of enhanced validation approaches and regulatory requirements for ATMPs. 

Also speaking

Ricardo P. Baptista

Chief Technology Officer • Alder Therapeutics AB

Lydia Frick

Manager Market Access • SKC Beratungsgesellschaft mbH

Alessandra De Riva

Head of Process Development and R&D  • Advent Bioservices Ltd

Event Info


Innovation Zone

Find out more about the Innovation Zone at Advanced Therapies Europe.

Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.